EDIT-301

Gene Editing Race Between Editas and Vertex, CRISPR Heats Up
BioSpace
Mon, 06/12/23 - 09:58 am
gene editing
Editas Medicine
Vertex Pharmaceuticals
CRISPR Therapeutics
EDIT-301
sickle cell disease
beta thalassemia
Editas’ Novel Sickle Cell Therapeutic Shows Early Promise
BioSpace
Wed, 07/27/22 - 06:39 pm
Editas Medicine
clinical trials
EDIT-301
sickle cell disease
FDA tags Editas' thalassemia cell therapy an orphan drug as it rounds final bend in race to clinic
Fierce Biotech
Sun, 05/15/22 - 11:19 pm
Editas Medicine
FDA
beta thalassemia
EDIT-301
Editas sees clinical promise with new FDA pediatric disease tag for another blood disorder
Fierce Biotech
Tue, 04/26/22 - 10:15 pm
Editas Medicine
EDIT-301
CRISPR
beta thalassemia
Why Editas Medicine Stock Is Tumbling Today
Motley Fool
Mon, 01/11/21 - 06:50 pm
Editas Medicine
JPMHC 2021
EDIT-301
EDIT-101